Key Takeaways Data and Services revenues for TEM rose 26.1% as Insights bookings hit $150 million. Tempus AI expanded capabilities with the Paige acquisition and a deeper Northwestern Medicine partnership. TEM broadened Tempus Next into breast cancer, adding real-time insights to support guideline-based care. Tempus AI’s (TEM) third-quarter 2025 results highlight the growing strategic importance of its Insights and Data & Services business, which is emerging as a high-margin and scalable revenue stream beyo ...